Psychopharmacology 2-Day Conference – Perry W. Buffington

12 Hours 13 MinutesSpend two action-packed days learning about the newest advances in psychopharmacology and contemporary trends in medication management. From his unique perspective, Dr. Perry Buffington teaches psychopharmacology thoughtfully, with an emphasis on the experience of the client. Dr. Buffington’s years of experience in mental health and passion for clients, shines through in the detail and thoroughness of his presentation.Purchase Psychopharmacology 2-Day Conference – Perry W. Buffington courses at here with PRICE $299.99 $95Learn current understanding of how & why mental health medications workUnderstand which medications are evidenced-based to best treat which disordersImprove your clients’ responses and clinical outcomes to medicationsHelp your clients recognize side effects and learn how to manage themLearn about new trends in prescribingUnderstand current controversies in the fieldNew and emerging ethical dilemmas both prescribing and non-prescribing clinicians face dailySpend two action-packed days learning about the newest advances in psychopharmacology and contemporary trends in medication management. From his unique perspective, Dr. Perry Buffington teaches psychopharmacology thoughtfully, with an emphasis on the experience of the client. Dr. Buffington’s years of experience in mental health and passion for clients, shines through in the detail and thoroughness of his presentation.Clients often only have a few minutes with their prescriber and require additional support. It’s vital that you are able to answer their questions, help manage side effects and understand reactions. Designed for counselors, nurses, psychotherapists, psychologists, and other mental health professionals, Dr. Buffington provides the information you need in order to best help your clients.This conference allows time for exploration of underrepresented areas, including ADHD, substance use disorders and psychopharmacological ethics. Take home specialized guidelines for geriatrics, and clients with chronic pain. Discuss how the DSM-5® and the Affordable Healthcare Law have impacted prescribing patterns and the use of psychotropics in newly defined diagnoses. In addition to a general ‘nuts and bolts’ review of medications, you will examine case examples, discuss medication controversies and how to effectively collaborate with prescribing practitioners. You will find this conference to have the most up- to-date medication information and how to use it most effectively with your client.Satisfaction GuaranteeYour satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.ADA NeedsWe would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.Analyze the historical antecedents of psychopharmacological products and their relation to today’s psychotropic medications.Designate the mechanism of action of today’;s psychotropic medications and how it relates to your clients.Breakdown the process of medication selection and receptor activation/blocking for specific disorders.Communicate the side effects including nutritional, cognitive, sexual, and behavioral associated with psychotropic medications.Specify how medications are chosen for mood disorders and specific patient characteristics.Compile medication treatment options for your clients with ADHD.Determine the unique medication considerations for geriatric clients.Determine acute and chronic pain and methods of treatment.Analyze future trends, including preventing side effects vs. managing side effects.Establish ethical issues specifically relating to the child and adolescent population as it relates to clinical psychopharmacology.Apply traditional standards (autonomy, beneficence, nonmaleficence, confidentiality, veracity) of ethical behavior to issues peculiar to the practice of clinical psychopharmacology.Explore specific ethical issues and their resolve to the everyday practice of clinical psychopharmacology.DAY ONEPSYCHOPHARMACOLOGYHistorical antecedents of modern psychopharmacologyDiagnostic issuesClarification of termsDrug metabolism concepts: pharmacokinetics & pharmacodynamicsDrug mechanism of actionPlacebo & NoceboPharmacotherapy vs. PharmacotherapyDeveloping highly effective collaborations with prescribersDEPRESSIVE DISORDERSBiogenic Amine, Cortisol, Down-Regulation, & Neurotropic HypothesesNeurochemistry of depressionTypes of anti-depressantsPreventing side effectsTardive Dysphoria: real or imagined?ANXIETY DISORDERS & OBSESSIVE COMPULSIVE DISORDERS & TRAUMA RELATED DISORDERSNeurochemistry of anxietyGAD, panic disorders, phobiasOCDPTSDPhysiological interventionsAnti-anxiety medicationsAnti-depressantsNon-pharmacologic optionsBenzodiazepines: risks and benefitsPreventing side effectsBIPOLAR DISORDERSNeurochemistryThe Bipolar Spectrum & DSM-5® ChangesMood stabilizersLithiumAnti-convulsants & neuromodulatorsTypical, atypical, & third-generation antipsychoticsEffective strategies for improving outcomes for clientsPSYCHOTIC DISORDERS/ SCHIZOPHRENIANeurochemistry of psychosis and schizophreniaAntipsychotic Medications:First generation (typical)Second generation (atypical)Managing side effectsExtrapyramidal symptoms and TDMetabolic problems- what blood tests are needed and whenPreventing Diabetes MellitusRecognizing hyperprolactinemia- and why you need to knowUse of atypical antipsychotics for multiple disordersLIMITATIONS OF THE RESEARCH & POTENTIAL RISKSDAY TWOATTENTIONAL DISORDERSDifferential diagnosisNeurochemistry of ADHDTreatment controversiesSubstance abuse and ADHDStimulant medicationsNon-stimulant optionsPreventing side effectsSUBSTANCE ABUSE DISORDERSNeurochemistry of addictionNegative reinforcement & creation of habitsAlcoholCaffeineNicotineCannabisOpiatesPCP & KetamineMDMA (Ecstasy)Energy vs. Chill DrinksOver-the-counter & herbal psychopharmacologyAddiction treatmentsBehavioral addictionsSPECIAL POPULATIONSSpecialized guidelines for geriatric patientsDementia treatmentSlow vs. rapid metabolizers (genetic polymorphisms)TREATING CLIENTS PAINAcute vs. chronic painAlternatives to pharmacologyPain vs. depression: which comes first?ETHICS & PSYCHOPHARMACOLOGYHigh-risk pharmacology & psychopharmacologyOff-label use of medicationsPrescribing for childrenElective psychopharmacologyMarketing of mental illnessPolypharmacyInformed vs. uninformed consentPatient & third party pressuresProfessional boundariesEthics associated with medical errorsRole of placeboFUTURE TRENDSChange of mind: preventing vs. managing side effectsMedicalization of normalComputer assisted devicesNew meds, new diagnoses, new theories, new normalTop 10 Medical EmergenciesIntegrating psychotherapy with psychopharmacologyLIMITATIONS OF THE RESEARCH & POTENTIAL RISKSTag: Psychopharmacology 2-Day Conference – Perry W. Buffington Review. Psychopharmacology 2-Day Conference – Perry W. Buffington download. Psychopharmacology 2-Day Conference – Perry W. Buffington discount.Purchase Psychopharmacology 2-Day Conference – Perry W. Buffington courses at here with PRICE $299.99 $95